19-054 - Evaluation and Safety of 2 Dose Regimens of Intravenous Study Medication for Postoperative Gastrointestinal Dysfunction in Participants Undergoing Large- and Small-Bowel Resection
Status: openTAK-954-2004: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large– and Small–bowel Resection
Treatment for laparoscopic-assisted or open partial small- or large- bowel resection.
Contact Us
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by email at clinical.trials@health.southalabama.edu.
Description
| The purpose of this study is to assess the efficacy and safety of intravenous (IV) TAK-954 for accelerating the recovery of gastrointestinal (GI) function postsurgery in participants undergoing open or laparoscopic-assisted partial small- or large-bowel resection. |
Providers Associated With This Trial
Principle Investigator
Sub Investigators
![Leander Grimm]()
View ProfileLeander M. Grimm, Jr., M.D., F.A.C.S., F.A.S.C.R.S.Colorectal SurgeonDirector of General Surgery Residency Program; Associate Professor of Surgery![Greire Iliff]()
View ProfileGreire Iliff, CRNPNurse Practitioner
This link will open in a new tab or window.